Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: My son passed away; the cause of death was bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology; My son passed away; the cause of death was bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the parent.  A 24-year-old male patient received BNT162b2 (BNT162B2), on 02Dec2021 as dose 3 (booster), single (Lot number: PF2593) at the age of 23 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 2, LOT# EW0153), administration date: 28Apr2021, when the patient was 23-year-old, for COVID-19 Immunization; Bnt162b2 (Dose 1, LOT# EW0153), administration date: Apr2021, when the patient was 23 years old, for COVID-19 Immunization. The following information was reported: PULMONARY EMBOLISM (death, medically significant), DEEP VEIN THROMBOSIS (death, medically significant), outcome "fatal" and all described as "My son passed away; the cause of death was bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology". The patient date of death was 28Oct2022. Reported cause of death: "bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology". It was not reported if an autopsy was performed. Clinical course: the reporter just obtain the final test certification and all type of report and the patient was on a product made by Pfizer and when he was on the product he was on the vaccine, so he had not just receive the vaccine but he received the vaccine a month before. He was not taking any other medicine at that time. He had received COVID-19 vaccine made by Pfizer, he had received the vaccine back in Dec2021 that was the last booster that he receive but he passed away in Oct2022, so many months later but the reporter want to make sure that this case was reported and there was awareness he was not drawing any conclusion but want to make sure that was awareness of this event.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events: "Pulmonary embolism", "Deep vein thrombosis" and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.   The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology; bilateral Pulmonary Thromboembolism due to deep vein thrombosis of lower extremity of undetermined Etiology